Glycemic Control and Adult Height: A Nationwide Swedish Cohort Study on Childhood Type 1 Diabetes.

IF 5.1 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Journal of Clinical Endocrinology & Metabolism Pub Date : 2025-07-15 DOI:10.1210/clinem/dgae809
Awad I Smew, Cecilia Lundholm, Tong Gong, Paul Lichtenstein, Lars Sävendahl, Catarina Almqvist
{"title":"Glycemic Control and Adult Height: A Nationwide Swedish Cohort Study on Childhood Type 1 Diabetes.","authors":"Awad I Smew, Cecilia Lundholm, Tong Gong, Paul Lichtenstein, Lars Sävendahl, Catarina Almqvist","doi":"10.1210/clinem/dgae809","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Normal growth throughout childhood and adolescence is considered an indicator of adequate glycaemic control in patients with type 1 diabetes. While it has been suggested that growth in type 1 diabetes is reduced, the literature is conflicting and differences in final adult height and the risk of short stature depending on glycaemic control remain largely unexplored.</p><p><strong>Objective: </strong>This work aims to assess adult height outcomes across levels of glycemic control in children and adolescents with type 1 diabetes, as well as to investigate the effect of sex, age at disease onset, and timing of glycemic control in relation to puberty.</p><p><strong>Methods: </strong>In this population-based Swedish cohort study, we collected data on glycemic control and height from specialist health-care visits of all individuals with childhood-onset type 1 diabetes in the National Diabetes Register. Using linear and logistic regression, we compared suboptimal (glycated hemoglobin A1c [HbA1c] 53-75 mmol/mol [7.0-9.0%]) and poor (HbA1c > 75 mmol/mol [>9.0%]) to optimal (HbA1c < 53 mmol/mol [<7.0%]) glycemic control in relation to final adult height and the risk of short stature.</p><p><strong>Results: </strong>Poor glycemic control was associated with lower final adult height (-2.91 cm [95% CI, -3.48 to -2.33] for males, -1.83 cm [-2.42 to -1.23] for females) as well as a higher risk of short stature in males (odds ratio 1.90 [1.07-3.35]) but not in females (0.73 [0.36-1.51]). For females, adult height was lower only among those with type 1 diabetes since before puberty and if the poor glycemic control occurred before puberty. For males, adult height was lower irrespective of their age at diabetes onset, but only if they had poor glycemic control during or after puberty.</p><p><strong>Conclusion: </strong>Poor glycemic control after the onset of type 1 diabetes, compared to optimal control, is associated with lower adult height in males and females. The prepubertal period seems to be more critical for females than males.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e2765-e2777"},"PeriodicalIF":5.1000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261078/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae809","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Normal growth throughout childhood and adolescence is considered an indicator of adequate glycaemic control in patients with type 1 diabetes. While it has been suggested that growth in type 1 diabetes is reduced, the literature is conflicting and differences in final adult height and the risk of short stature depending on glycaemic control remain largely unexplored.

Objective: This work aims to assess adult height outcomes across levels of glycemic control in children and adolescents with type 1 diabetes, as well as to investigate the effect of sex, age at disease onset, and timing of glycemic control in relation to puberty.

Methods: In this population-based Swedish cohort study, we collected data on glycemic control and height from specialist health-care visits of all individuals with childhood-onset type 1 diabetes in the National Diabetes Register. Using linear and logistic regression, we compared suboptimal (glycated hemoglobin A1c [HbA1c] 53-75 mmol/mol [7.0-9.0%]) and poor (HbA1c > 75 mmol/mol [>9.0%]) to optimal (HbA1c < 53 mmol/mol [<7.0%]) glycemic control in relation to final adult height and the risk of short stature.

Results: Poor glycemic control was associated with lower final adult height (-2.91 cm [95% CI, -3.48 to -2.33] for males, -1.83 cm [-2.42 to -1.23] for females) as well as a higher risk of short stature in males (odds ratio 1.90 [1.07-3.35]) but not in females (0.73 [0.36-1.51]). For females, adult height was lower only among those with type 1 diabetes since before puberty and if the poor glycemic control occurred before puberty. For males, adult height was lower irrespective of their age at diabetes onset, but only if they had poor glycemic control during or after puberty.

Conclusion: Poor glycemic control after the onset of type 1 diabetes, compared to optimal control, is associated with lower adult height in males and females. The prepubertal period seems to be more critical for females than males.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血糖控制与成年身高:一项关于儿童 1 型糖尿病的全国性瑞典队列研究。
目的:评估不同血糖控制水平下 1 型糖尿病儿童和青少年的成年身高结果,并研究性别、发病年龄以及与青春期相关的血糖控制时间的影响:在这项基于人群的瑞典队列研究中,我们从全国糖尿病登记册中所有儿童期发病的 1 型糖尿病患者的专科医疗就诊中收集了有关血糖控制和身高的数据。通过线性回归和逻辑回归,我们比较了次优(HbA1c 53-75 mmol/mol [7.0-9.0%])和较差(HbA1c >75 mmol/mol [>9.0%])与最优(HbA1c 53-75 mmol/mol [7.0-9.0%])血糖控制结果:血糖控制不佳与男性最终成年身高较低(男性-2.91 厘米 [95% CI - 3.48, -2.33],女性-1.83 厘米 [-2.42, -1.23])以及身材矮小的风险较高(几率比 1.90 [1.07, 3.35])有关,但与女性(0.73 [0.36, 1.51])无关。就女性而言,只有在青春期前就患有 1 型糖尿病,以及在青春期前血糖控制不佳的情况下,成年身高才会降低。对于男性而言,无论糖尿病发病年龄如何,成年身高都会降低,但只有在青春期或青春期后血糖控制不佳的情况下,成年身高才会降低:结论:与最佳血糖控制相比,1 型糖尿病发病后血糖控制不佳与男性和女性成年身高较低有关。对女性而言,青春前期似乎比男性更为关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
期刊最新文献
Transforming Women's Health Research-The Time Is Now. Elucidating the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis. Wake Up and Smell-the Cortisol? Diabetes Risk in Young Survivors of Childhood Cancer: A Need for Prevention and Survivor-specific Treatment Strategies. Unraveling the Complexity of Primary Ovarian Insufficiency Genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1